Flavonoid dimer FD18 is a new class of dimeric P-gp modulator that can modulate multidrug resistance toward paclitaxel, vinblastine, vincristine, doxorubicin, daunorubicin, and mitoxantrone in human breast cancer LCC6MDR in vitro. The gene discussed is PGP; the disease is breast carcinoma.